Detalles de la búsqueda
1.
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.
Rheumatology (Oxford)
; 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341669
2.
Subgroup Analyses by European Country-Specific Reimbursement Requirements Confirm Efficacy for Ixekizumab in Psoriasis.
J Drugs Dermatol
; 21(6): 659-667, 2022 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674763
3.
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Ann Rheum Dis
; 79(10): 1310-1319, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660977
4.
Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
BMC Psychiatry
; 20(1): 123, 2020 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32169077
5.
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
Int J Neuropsychopharmacol
; 20(1): 40-49, 2017 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27927736
6.
Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK.
J Ment Health Policy Econ
; 18(4): 185-200, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729007
7.
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis.
RMD Open
; 10(1)2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296801
8.
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.
Inflamm Bowel Dis
; 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603837
9.
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial.
Dermatol Pract Concept
; 12(2): e2022104, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35646453
10.
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis.
J Dermatolog Treat
; 33(3): 1652-1660, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33641593
11.
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2H.
Rheumatol Ther
; 9(1): 109-125, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34709605
12.
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.
Nord J Psychiatry
; 65(6): 403-13, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21770821
13.
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52.
Clin Rheumatol
; 40(12): 4943-4954, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34515902
14.
Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain.
BMJ Open
; 10(8): e032552, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32792421
15.
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK.
Pharmacoecon Open
; 4(4): 635-648, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166657
16.
Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis.
RMD Open
; 6(1)2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094304
17.
Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study.
Rheumatol Ther
; 7(4): 1021-1035, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200394
18.
Validation of a French hospitalized patients' satisfaction questionnaire: the QSH-45.
Int J Qual Health Care
; 21(4): 243-52, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19549673
19.
The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe.
BMC Psychiatry
; 8: 57, 2008 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-18638382
20.
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA.
Clinicoecon Outcomes Res
; 10: 443-456, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30147350